{"id":92299,"date":"2026-06-25T22:31:13","date_gmt":"2026-06-25T22:31:13","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/92299\/"},"modified":"2026-06-25T22:31:13","modified_gmt":"2026-06-25T22:31:13","slug":"former-biopharm-director-heads-to-prison-for-insider-trading-ahead-of-novartis-purchase","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/92299\/","title":{"rendered":"Former biopharm director heads to prison for insider trading ahead of Novartis purchase"},"content":{"rendered":"<p class=\"wp-block-paragraph\">A former director of biopharmaceutical company, Chinook Therapeutics, has been sentenced to prison for insider trading related to the company\u2019s $3.2 billion sale to Novartis in 2023, a fraud detected through data analysis by the U.S. Securities and Exchange Commission (SEC).<\/p>\n<p><img loading=\"lazy\" data-recalc-dims=\"1\" decoding=\"async\" width=\"780\" height=\"278\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/06\/cwmembershi_484848-2.jpg\" alt=\"\" class=\"wp-image-80440\"  \/><\/p>\n<p>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.complianceweek.com\/author\/adrianne-appel\/\" rel=\"author nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" alt=\"Avatar photo\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/06\/appelheadshot1_303217-120x120.jpg\"  class=\"avatar avatar-120 photo\" height=\"120\" width=\"120\"\/>\t\t\t\t\t\t\t\t\t\t\t<\/a><\/p>\n<p>\n\t\t\t\t\t\t\tAdrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government.&#13;<br \/>\n&#13;<br \/>\nEmail: adrianne.appel@complianceweek.com&#13;<br \/>\n&#13;<br \/>\nLinkedIn:&#8230;\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"author-link\" href=\"https:\/\/www.complianceweek.com\/author\/adrianne-appel\/\" rel=\"author nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t\t\tMore by Adrianne Appel\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"A former director of biopharmaceutical company, Chinook Therapeutics, has been sentenced to prison for insider trading related to&hellip;\n","protected":false},"author":2,"featured_media":92300,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[46320,46321,206,16342],"class_list":["post-92299","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-cw-subscriber-only","tag-doj","tag-novartis","tag-sec"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116813121979222546","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/92299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=92299"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/92299\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/92300"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=92299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=92299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=92299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}